Originalarbeiten (Internationale Journale)

Erst- oder Letztautor

• Claassen J, Koenen LR, Ernst TM, Labrenz F, Theysohn N, Forsting M, Bingel U, Timmann D, Elsenbruch S. (2020)  Cerebellum is more concerned about visceral than somatic pain. J Neurol Neurosurg Psychiatry 91: 218-9.
• Mamlins A, Hulst T, Donchin O, Timmann D, Claassen J. (2019) No effects of cerebellar transcranial direct current stimulation (tDCS) on force field and visuomotor reach adaptation in young and healthy subjects. J Neurophysiol. 121: 2112-25.
• Claassen J*, Labrenz F*, Ernst TM, Icenhour A, Langhorst J, Forsting M, Timmann D, Elsenbruch S. (2017) Altered Cerebellar Activity in Visceral Pain-Related Fear Conditioning in Irritable Bowel Syndrome. Cerebellum 16: 508-17.
• Claassen J, Bardins S, Spiegel R, Strupp M, Kalla R. (2016) Gravity matters: Motion perceptions modified by direction and body position. Brain Cogn. 106:72-7.
• Claassen J, Mazilescu L, Thieme A, Bracha V, Timmann D. (2016) Lack of renewal effect in extinction of naturally acquired conditioned eyeblink responses, but possible dependency on physical context. Exp Brain Res. 234: 151-9.
• Feil K*, Claassen J*, Bardins S, Teufel J, Krafczyk S, Schneider E, Schniepp R, Jahn K, Kalla R, Strupp M (2013) Effect of chlorzoxazone in patients with downbeat nystagmus: A pilot trial. Neurology 81: 1152-8.
• Claassen J*, Feil K, Bardins S, Teufel J, Spiegel R, Kalla R, Schneider E, Jahn K, Schniepp R, Strupp M (2013) Dalfampridine in patients with downbeat nystagmus-an observational study. Journal of neurology 260:1992-1996.
• Claassen J*, Spiegel R*, Kalla R, Faldon M, Kennard C, Danchaivijitr C, Bardins S, Rettinger N, Schneider E, Brandt T, Jahn K, Teufel J, Strupp M, Bronstein A. (2013) A randomised double-blind, cross-over trial of 4-aminopyridine for downbeat nystagmus--effects on slowphase eye velocity, postural stability, locomotion and symptoms. J Neurol Neurosurg Psychiatry. 84: 1392-9.

* geteilte Erstautorenschaft

Ko-Autor

• Steiner KM, Gisbertz Y, Chang DI, Koch B, Uslar E, Claassen J, Wondzinski E, Ernst TM, Göricke SL, Siebler M, Timmann D (2019)  Extinction and Renewal of Conditioned Eyeblink Responses in Focal Cerebellar Disease. Cerebellum 18:166-177.
• Spiegel R, Claassen J, Teufel J, Bardins S, Schneider E, Lehrer Rettinger N, Jahn K, da Silva FA, Hahn A, Farahmand P, Brandt T, Strupp M, Kalla R. (2016) Resting in darkness improves downbeat nystagmus: evidence from an observational study. Ann N Y Acad Sci. 1375:66-73.
• Spiegel R, Farahmand P, Da Silva FA, Claassen J, Kalla R (2012) Preventing road injuries in children by applying feedback devices. Traffic injury prevention 13:49-54.
• Kalla R, Spiegel R, Claassen J, Bardins S, Hahn A, Schneider E, Rettinger N, Glasauer S, Brandt T, Strupp M (2011) Comparison of 10-mg doses of 4-aminopyridine and 3,4-diaminopyridine for the treatment of downbeat nystagmus. Journal of neuro-ophthalmology 31:320-325.
• Kalla R, Muggleton N, Spiegel R, Bueti D, Claassen J, Walsh V, Bronstein A (2011) Adaptive motion processing in bilateral vestibular failure. J Neurol Neurosurg Psychiatry 82:1212-1216.
• Strupp M, Kalla R, Claassen J, Adrion C, Mansmann U, Klopstock T, Freilinger T, Neugebauer H, Spiegel R, Dichgans M, Lehmann-Horn F, Jurkat-Rott K, Brandt T, Jen JC, Jahn K (2011) A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias. Neurology 77:269-275.
• Levin J, Krafczyk S, Valkovic P, Eggert T, Claassen J, Botzel K (2009) Objective measurement of muscle rigidity in Parkinsonian patients treated with subthalamic stimulation. Mov Disord. 24:57-63.

Fallmitteilungen

• Claassen J, Gerding WM, Kastrup O, Uslar E, Goericke S, Timmann D. (2015) Excessive brain iron accumulation in spinocerebellar ataxia type 17. Neurology. 84:212-213.

Übersichtsarbeiten in Zeitschriften

• Ilg W., Bastian A. J., Boesch S., Burciu R. G., Celnik, P. Claassen J., Feil K., Kalla R., Miyai I., Nachbauer W., Schöls L., Strupp M., Synofzik M., Teufel J., Timmann D. (2014) Consensus paper: management of degenerative cerebellar disorders. Cerebellum 13: 248-268.

Leserbriefe

• Mademan I, Harmuth F, Giordano I, Timmann D, Magri S, Deconinck T, Claaßen J, Jokisch D, Genc G, Di Bella D, Romito S, Schüle R, Züchner S, Taroni F, Klockgether T, Schöls L, De Jonghe P, Bauer P, Consortium E, Baets J, Synofzik M. (2016) Multisystemic SYNE1 ataxia: confirming the high frequency and extending the mutational and phenotypic spectrum. Brain. 139 (Pt8): e46.
• Feil K, Claassen J, Bardins S, Teufel J, Habs M, Kalla R, Strupp M (2013a) Transition from downbeat to upbeat nystagmus caused by 4-aminopyridine. J Neurol. 260:1426-1428.

Publizierte Abstracts

• Mamlins A, Hulst T, Donchin O, Timmann D,  Claaßen J. (2017) Cerebellar tDCS effects on the adaptation of arm reaching movements to force-field and visuomotor perturbations. Clinical Neurophysiology, Volume 128, Issue 3, 2017, Page e132, ISSN 1388-2457, https://doi.org/10.1016/ j.clinph.2016.10.357.
• Claaßen J , Kalla R, Stephan T, Flanagin V, Spiegel R, Strupp M, Jahn K. (2012) Dependance of supraspinal locomotor control on speed and gait pattern – an fMRI study. Klin Neurophysiol 43 - P134. DOI: 10.1055/s-0032-1301684.

Sonstiges

Veröffentlichung Studienprotokoll

• Feil K, Adrion C, Teufel J, Bösch S, Claassen J, Giordano I, Hengel H, Jacobi H, Klockgether T, Klopstock T, Nachbauer W, Schöls L, Stendel C, Uslar E, van de Warrenburg B, Berger I, Naumann I, Bayer O, Müller HH, Mansmann U, Strupp M. (2017) Effects of acetyl-DL-leucine on cerebellar ataxia (ALCAT trial): study protocol for a multicenter, multinational, randomized, double-blind, placebo-controlled, crossover phase III trial. BMC Neurol. 10:17(1):7.